☰

Liwei Rong, Ph.D. - Publications

Affiliations: 
2001 McGill University, Montreal, QC, Canada 
Area:
Molecular Biology
Tree Info Similar researchers PubMed Report error

34 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Wang S, Rong L. Stochastic population switch may explain the latent reservoir stability and intermittent viral blips in HIV patients on suppressive therapy. Journal of Theoretical Biology. 360: 137-48. PMID 25016044 DOI: 10.1016/J.Jtbi.2014.06.042  0.342
2012 Jia R, Pan Q, Ding S, Rong L, Liu SL, Geng Y, Qiao W, Liang C. The N-terminal region of IFITM3 modulates its antiviral activity by regulating IFITM3 cellular localization. Journal of Virology. 86: 13697-707. PMID 23055554 DOI: 10.1128/Jvi.01828-12  0.459
2011 Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. Journal of Virology. 85: 2126-37. PMID 21177806 DOI: 10.1128/Jvi.01531-10  0.528
2009 Rong L, Perelson AS. Modeling latently infected cell activation: viral and latent reservoir persistence, and viral blips in HIV-infected patients on potent therapy. Plos Computational Biology. 5: e1000533. PMID 19834532 DOI: 10.1371/Journal.Pcbi.1000533  0.325
2009 Zhou Y, Rong L, Zhang J, Aloysius C, Pan Q, Liang C. Insulin-like growth factor II mRNA binding protein 1 modulates Rev-dependent human immunodeficiency virus type 1 RNA expression. Virology. 393: 210-20. PMID 19726068 DOI: 10.1016/J.Virol.2009.08.004  0.551
2009 Rong L, Perelson AS. Modeling HIV persistence, the latent reservoir, and viral blips. Journal of Theoretical Biology. 260: 308-31. PMID 19539630 DOI: 10.1016/J.Jtbi.2009.06.011  0.361
2009 Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, Aloysius C, Guo F, Liu SL, Wainberg MA, Liang C. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. Journal of Virology. 83: 7536-46. PMID 19474106 DOI: 10.1128/Jvi.00620-09  0.586
2009 Pan Q, Rong L, Zhao X, Liang C. Fragile X mental retardation protein restricts replication of human immunodeficiency virus type 1. Virology. 387: 127-35. PMID 19249802 DOI: 10.1016/J.Virol.2009.02.006  0.529
2009 Rong L, Perelson AS. Asymmetric division of activated latently infected cells may explain the decay kinetics of the HIV-1 latent reservoir and intermittent viral blips. Mathematical Biosciences. 217: 77-87. PMID 18977369 DOI: 10.1016/J.Mbs.2008.10.006  0.344
2009 Zhang J, Rong L, Wainberg MA, Liang C. Mechanistic study of BST-2 down-modulation by HIV-1 Vpu Retrovirology. 6. DOI: 10.1186/1742-4690-6-S2-P97  0.586
2008 Zhou Y, Rong L, Lu J, Pan Q, Liang C. Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly. Journal of Virology. 82: 5683-92. PMID 18385235 DOI: 10.1128/Jvi.00189-08  0.545
2008 Ma J, Rong L, Zhou Y, Roy BB, Lu J, Abrahamyan L, Mouland AJ, Pan Q, Liang C. The requirement of the DEAD-box protein DDX24 for the packaging of human immunodeficiency virus type 1 RNA. Virology. 375: 253-64. PMID 18289627 DOI: 10.1016/J.Virol.2008.01.025  0.548
2008 Colina R, Costa-Mattioli M, Dowling RJ, Jaramillo M, Tai LH, Breitbach CJ, Martineau Y, Larsson O, Rong L, Svitkin YV, Makrigiannis AP, Bell JC, Sonenberg N. Translational control of the innate immune response through IRF-7. Nature. 452: 323-8. PMID 18272964 DOI: 10.1038/Nature06730  0.307
2008 Zhou Y, Ma J, Bushan Roy B, Wu JY, Pan Q, Rong L, Liang C. The packaging of human immunodeficiency virus type 1 RNA is restricted by overexpression of an RNA helicase DHX30. Virology. 372: 97-106. PMID 18022663 DOI: 10.1016/J.Virol.2007.10.027  0.536
2003 Rong L, Russell RS, Hu J, Laughrea M, Wainberg MA, Liang C. Deletion of stem-loop 3 is compensated by second-site mutations within the Gag protein of human immunodeficiency virus type 1. Virology. 314: 221-8. PMID 14517075 DOI: 10.1016/S0042-6822(03)00405-7  0.654
2002 Kameoka M, Morgan M, Binette M, Russell RS, Rong L, Guo X, Mouland A, Kleiman L, Liang C, Wainberg MA. The Tat protein of human immunodeficiency virus type 1 (HIV-1) can promote placement of tRNA primer onto viral RNA and suppress later DNA polymerization in HIV-1 reverse transcription. Journal of Virology. 76: 3637-45. PMID 11907203 DOI: 10.1128/Jvi.76.8.3637-3645.2002  0.679
2002 Brulé F, Marquet R, Rong L, Wainberg MA, Roques BP, Le Grice SF, Ehresmann B, Ehresmann C. Structural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complex. Rna (New York, N.Y.). 8: 8-15. PMID 11873759 DOI: 10.1017/S1355838202010981  0.572
2001 Rong L, Liang C, Hsu M, Guo X, Roques BP, Wainberg MA. HIV-1 nucleocapsid protein and the secondary structure of the binary complex formed between tRNA(Lys.3) and viral RNA template play different roles during initiation of (-) strand DNA reverse transcription. The Journal of Biological Chemistry. 276: 47725-32. PMID 11602578 DOI: 10.1074/Jbc.M105124200  0.641
2001 Rong L, Russell RS, Hu J, Guan Y, Kleiman L, Liang C, Wainberg MA. Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals. Journal of Virology. 75: 7230-43. PMID 11461996 DOI: 10.1128/Jvi.75.16.7230-7243.2001  0.623
2001 Kameoka M, Rong L, Götte M, Liang C, Russell RS, Wainberg MA. Role for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication. Journal of Virology. 75: 2675-83. PMID 11222691 DOI: 10.1128/Jvi.75.6.2675-2683.2001  0.66
2000 Cen S, Khorchid A, Gabor J, Rong L, Wainberg MA, Kleiman L. Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1. Journal of Virology. 74: 10796-800. PMID 11044125 DOI: 10.1128/Jvi.74.22.10796-10800.2000  0.618
2000 Liang C, Rong L, Russell RS, Wainberg MA. Deletion mutagenesis downstream of the 5' long terminal repeat of human immunodeficiency virus type 1 is compensated for by point mutations in both the U5 region and gag gene. Journal of Virology. 74: 6251-61. PMID 10864634 DOI: 10.1128/Jvi.74.14.6251-6261.2000  0.603
2000 Hsu M, Rong L, de Rocquigny H, Roques BP, Wainberg MA. The effect of mutations in the HIV-1 nucleocapsid protein on strand transfer in cell-free reverse transcription reactions. Nucleic Acids Research. 28: 1724-9. PMID 10734191 DOI: 10.1093/Nar/28.8.1724  0.63
1999 Liang C, Rong L, Quan Y, Laughrea M, Kleiman L, Wainberg MA. Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site. Journal of Virology. 73: 7014-20. PMID 10400801 DOI: 10.1128/Jvi.73.8.7014-7020.1999  0.627
1999 Quan Y, Rong L, Liang C, Wainberg MA. Reverse transcriptase inhibitors can selectively block the synthesis of differently sized viral DNA transcripts in cells acutely infected with human immunodeficiency virus type 1. Journal of Virology. 73: 6700-7. PMID 10400767 DOI: 10.1128/Jvi.73.8.6700-6707.1999  0.575
1999 Liang C, Rong L, Cherry E, Kleiman L, Laughrea M, Wainberg MA. Deletion mutagenesis within the dimerization initiation site of human immunodeficiency virus type 1 results in delayed processing of the p2 peptide from precursor proteins. Journal of Virology. 73: 6147-51. PMID 10364374 DOI: 10.1128/Jvi.73.7.6147-6151.1999  0.642
1998 Cherry E, Liang C, Rong L, Quan Y, Inouye P, Li X, Morin N, Kotler M, Wainberg MA. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins. Journal of Molecular Biology. 284: 43-56. PMID 9811541 DOI: 10.1006/Jmbi.1998.1968  0.642
1998 Rong L, Liang C, Hsu M, Kleiman L, Petitjean P, de Rocquigny H, Roques BP, Wainberg MA. Roles of the human immunodeficiency virus type 1 nucleocapsid protein in annealing and initiation versus elongation in reverse transcription of viral negative-strand strong-stop DNA. Journal of Virology. 72: 9353-8. PMID 9765488 DOI: 10.1128/Jvi.72.11.9353-9358.1998  0.624
1998 Quan Y, Inouye P, Liang C, Rong L, Götte M, Wainberg MA. Dominance of the E89G substitution in HIV-1 reverse transcriptase in regard to increased polymerase processivity and patterns of pausing. The Journal of Biological Chemistry. 273: 21918-25. PMID 9705331 DOI: 10.1074/Jbc.273.34.21918  0.614
1998 Liang C, Rong L, Götte M, Li X, Quan Y, Kleiman L, Wainberg MA. Mechanistic studies of early pausing events during initiation of HIV-1 reverse transcription. The Journal of Biological Chemistry. 273: 21309-15. PMID 9694891 DOI: 10.1074/Jbc.273.33.21309  0.566
1998 Liang C, Rong L, Laughrea M, Kleiman L, Wainberg MA. Compensatory point mutations in the human immunodeficiency virus type 1 Gag region that are distal from deletion mutations in the dimerization initiation site can restore viral replication. Journal of Virology. 72: 6629-36. PMID 9658109 DOI: 10.1128/Jvi.72.8.6629-6636.1998  0.681
1997 Liang C, Rong L, Morin N, Cherry E, Huang Y, Kleiman L, Wainberg MA. The roles of the human immunodeficiency virus type 1 Pol protein and the primer binding site in the placement of primer tRNA(3Lys) onto viral genomic RNA. Journal of Virology. 71: 9075-86. PMID 9371564 DOI: 10.1128/Jvi.71.12.9075-9086.1997  0.686
1997 Liang C, Li X, Rong L, Inouye P, Quan Y, Kleiman L, Wainberg MA. The importance of the A-rich loop in human immunodeficiency virus type 1 reverse transcription and infectivity. Journal of Virology. 71: 5750-7. PMID 9223461 DOI: 10.1128/Jvi.71.8.5750-5757.1997  0.681
1994 Ito H, Minamoto N, Watanabe T, Goto H, Rong LT, Sugiyama M, Kinjo T, Mannen K, Mifune K, Konobe T. A unique mutation of glycoprotein gene of the attenuated RC-HL strain of rabies virus, a seed virus used for production of animal vaccine in Japan. Microbiology and Immunology. 38: 479-82. PMID 7968680 DOI: 10.1111/j.1348-0421.1994.tb01812.x  0.312
Show low-probability matches.